Natco Pharma Ltd on Thursday said it has received approval from the US health regulator for its generic version of Everolimus tablets for oral suspension indicated for patients with tuberous ...

under its brand Sovaldi. On 11 March 2015, Natco Pharma announced that it is the first company in India to get approval for generic sofosbuvir tablets, 400mg, from Drugs Controller General (India).

The Delhi High Court has denied an injunction request from Swiss pharma major La Hoffman Roche on March 25, in an alleged patent infringement case against Natco Pharma, potentially opening the ...

The Delhi High Court has rejected an interim injunction plea from Swiss pharma major F Hoffmann La Roche against Hyderabad-based Natco Pharma in a patent infringement dispute related to the former's ...

The Delhi High Court on Monday refused to allow a lawsuit filed by Swiss pharmaceutical company Roche that sought to restrain Indian drug maker Natco Pharma from manufacturing Risdiplam ...

NATCO Pharma Ltd on Wednesday reported a 37.75 per cent decline in consolidated net profit to Rs 132.4 crore in the December quarter, hit by a drop in formulations exports. The company had posted ...

A two-judge bench of Delhi High Court on Wednesday refrained Natco Pharma from launching the generic version of Swiss drugmaker Roche Pharma's patented drug Risdiplam until the hearing on April 2.